Method for treatment of angina and myocardial infarctions with omental lipids
US4778787A · kind A · utility
16Cited by
30References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 20, 1985 |
| Grant date | Oct 18, 1988 |
| Priority date | — |
| Expiry date | Dec 20, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Angiogenesis healing factors residing in omentum-derived lipid fractions with or without gangliosides or their synthetic equivalents can be used to treat myocardial ischemic conditions including but not limited to myocardial infarction, angina, as well as in heart transplant, vascular grafts, and re-opened vessels leading to improved vascularization, perfusion, collagenization and organization of said lesions; the involved and adjacent tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.